Medical Qigong for cancer patients: Pilot study of impact on quality of life, side effects of treatment and inflammation

被引：51

作者：

Oh, Byeongsang ^{[1
]}

Butow, Phyllis ^{[2
]}

Mullan, Barbara ^{[2
]}

Clarke, Stephen ^{[3
]}

机构：

[1] Univ Sydney, Fac Med, Sch Publ Hlth, Camperdown, NSW 2006, Australia

[2] Univ Sydney, Sch Psychol, Med Psychol Res Unit, Camperdown, NSW 2006, Australia

[3] Univ Sydney, Dept Med, Concord Hosp, Camperdown, NSW 2006, Australia

来源：

AMERICAN JOURNAL OF CHINESE MEDICINE | 2008年 / 36卷 / 03期

关键词：

cancer; quality of life; side effects of cancer treatment; inflammation biomarker (c-reactive protein); Medical Qigong; randomized clinical trial;

D O I：

10.1142/S0192415X08005904

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

Quality of life (QOL) of cancer patients is often diminished due to the side effects of treatment and symptoms of the disease itself. Medical Qigong (coordination of gentle exercise and relaxation through meditation and breathing exercise based on Chinese medicine theory of energy channels) may be an effective therapy for improving QOL, symptoms and side effects, and longevity of cancer patients. In this pilot study, the feasibility, acceptability, and impact of Medical Qigong (MQ) were evaluated on outcomes in cancer patients. Thirty patients diagnosed with heterogeneous cancers, were randomly assigned to two groups: a control group that received usual medical care and an intervention group who participated in a MQ program for 8 weeks in addition to receiving usual medical care. Randomization was stratified by completion of cancer treatment (n = 14) or under chemotherapy (n = 16). Patients completed measures before and after the program. Quality of life and symptoms were measured by the EORTC QLQ-C 30 and progress of disease by the inflammation biomarker (CRP: c-reactive protein) via a blood test was assessed. The MQ intervention group reported clinically significant improved global QOL scores pre- and post-intervention. The MQ intervention also reduced the symptoms of side effects of cancer treatment and inflammation biomarker (CRP) compare to the control group. Due to the small sample size, however, the results were not statistically significant between treatment and the control groups. Data from the pilot study suggest that MQ with usual medical treatment can enhance the QOL of cancer patients and reduce inflammation. This study needs a further investigation with a larger sample size.

引用

页码：459 / 472

页数：14

共 40 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2]

[Anonymous], CANC FACTS FIG 2007

[3]

[Anonymous], 2003, CLIN PRACTICE GUIDEL

[4]

Astin JA, 2003, J RHEUMATOL, V30, P2257

[5]

*AUSTR I HLTH WELF, 2005, CANC AUSTR

[6]

Benson H., 1983, RELAXATION RESPONSE

[7] Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients [J].

Carlson, LE ;

Speca, M ;

Patel, KD ;

Goodey, E .

PSYCHONEUROENDOCRINOLOGY, 2004, 29 (04) :448-474

[8] Complementary and alternative therapies for cancer [J].

Cassileth, BR ;

Deng, G .

ONCOLOGIST, 2004, 9 (01) :80-89

[9]

Cen Y., 1996, CHINESE QIGONG ESSEN

[10]

Chen Kevin, 2002, Integr Cancer Ther, V1, P345, DOI 10.1177/1534735402238187

← 1 2 3 4 →